ClinicalTrials.Veeva

Menu

3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008)

Organon logo

Organon

Status and phase

Completed
Phase 3

Conditions

Bipolar Disorder

Treatments

Drug: Olanzapine
Drug: Placebo
Drug: Asenapine

Study type

Interventional

Funder types

Industry

Identifiers

NCT00159744
P07008
A7501004 (Other Identifier)

Details and patient eligibility

About

Bipolar disorder is characterized by mood swings that range from high (manic) to low (depressed) states. Sometimes, symptoms of both depression and mania are present (mixed episodes). Asenapine is an investigational medication for the treatment of manic or mixed episodes of bipolar disorder. This is a 3-week study that will test the safety and efficacy of this medication. Patients will receive either asenapine, olanzapine (a medication that is already approved for the treatment of bipolar mania), or placebo (no active medication). Patients will be required to stay in the hospital for at least the first seven days of treatment. Patients that complete the 3 week study may be eligible to continue in extension studies for an additional 9 (study A7501006) to 49 (study A7501007) weeks.

Enrollment

488 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Have a DSMIV diagnosis of bipolar I disorder, current episode manic or mixed.

Exclusion criteria

  • Patients with unstable medical conditions or clinically significant laboratory abnormalities or patients who are rapid cyclers (ie. have had 4 or more (including current) mood episodes in the past 12 months); have any other psychiatric disorder other than bipolar I disorder as a primary diagnosis.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

488 participants in 3 patient groups, including a placebo group

Arm 1
Active Comparator group
Description:
Asenapine
Treatment:
Drug: Asenapine
Arm 2
Active Comparator group
Description:
Olanzapine
Treatment:
Drug: Olanzapine
Arm 3
Placebo Comparator group
Description:
Placebo
Treatment:
Drug: Placebo

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems